Becca Ziegler is only 24, but she already has her death planned out: Her corpse would be deep-frozen to minus-200°C with liquid nitrogen. Ziegler, a US tech firm worker based in Berlin, has signed up with Tomorrow Biostasis, a start-up in the German capital that offers to cryogenically freeze a person’s body after they die.
When the time comes, a team of medics would pump her full of a chemical solution to stop ice crystals from forming in her body and then transport her mortal remains to a storage facility in Switzerland.
The hope is that one day, medical technology might be advanced enough to bring her back to life. Many experts dismiss this gamble on the future as far-fetched, but Ziegler has decided to give it a shot.
Photo: Tomorrow Biostastis, via AFP
“I’m kind of curious to see what the future would be like and, in general, I like life,” said the Californian, who works in educational technology.
“So, if I could buy myself more time, that sounds really appealing,” she said.
Once a fringe pursuit reserved for eccentric billionaires, cryogenic freezing — also known as cryonics — has become more accessible over the past years.
Several companies offering cryopreservation have sprung up in the US and elsewhere, with about 500 people worldwide thought to have been frozen so far.
A persistent myth has it that Walt Disney, the creator of Mickey Mouse, is one of them, but this has been debunked, with BBC reporting in 2019 there is “zero evidence” for this.
Tomorrow Biostasis, founded in 2020, is thought to be the first such company offering the service in Europe. It offers to freeze your body after you die and store it for a membership fee of 50 euros (US$53) a month.
A lump-sum payment of 200,000 euros — or 75,000 euros if you opt to have just your brain frozen — is also due at the time of death, a cost that can be covered by a life insurance payout.
“One of the main goals of this company is to bring the cost down ... so that cryopreservation becomes available to whoever chooses to do it,” Tomorrow Biostasis cofounder Emil Kendziorra said.
Kendziorra, 38, from the western German city of Darmstadt, studied medicine and originally worked in cancer research, but said he became frustrated with the slow pace of developments in the field.
“The one big advantage of cryopreservation is that it is something that you can do right now,” he said.
When a client dies, Tomorrow Biostasis promises to dispatch a specially equipped ambulance and a medical team that starts cooling the body using ice and water as soon as possible.
The body is then infused with a “cryoprotectant” and transported to the facility in Switzerland where it is stored in a pod surrounded by liquid nitrogen and cooled to about minus-200°C.
Tomorrow Biostasis said it has about 700 paying members, and by the end of last year had cryopreserved four people.
The typical customer is aged 30 to 40, healthy, works in technology and is more likely to be male than female, Kendziorra said.
No one has ever been brought back to life after being cryopreserved, but proponents say recent advances in technology have made the prospect more plausible.
In an experiment almost a decade ago, scientists said they were able to cryopreserve the brain of a rabbit and recover it in near-perfect condition.
This year, researchers at China’s Fudan University reported using a new technique to freeze human brain tissue so that it regained normal function after thawing.
Nonetheless, some scientists voice deep skepticism about the bet on a future return to life.
Bringing a person back to life is still a remote prospect, said Holger Reinsch, head of the Cryo Competence Center at the ILK Dresden research institute for refrigeration technologies.
“We are rather critical of the concept of cryonics... I personally would advise you against such an endeavor,” he said. “The magic limit for the life-sustaining cryopreservation of tissue structures is a frog’s heart the size of a fingernail, and this has not changed since the 1970s.”
Even Kendziorra admitted that there are no guarantees.
“I think there’s a good chance for it, but do I know for sure? Absolutely not,” he said.
However, whatever happens in the future, Ziegler is confident she would not regret her decision.
“In some ways it’s weird,” she said. “But on the other hand, the alternative is to be put in a box in the ground and get eaten by worms.”
The EU and US are nearing an agreement to coordinate on producing and securing critical minerals, part of a push to break reliance on Chinese supplies. The potential deal would create incentives, such as minimum prices, that could advantage non-Chinese suppliers, according to a draft of an “action plan” seen by Bloomberg. The EU and US would also cooperate on standards, investments and joint projects, as well as coordinate on any supply disruptions by countries like China. The two sides are additionally seeking other “like-minded partners” to join a multicountry accord to help create these new critical mineral supply chains, which feed into
For weeks now, the global tech industry has been waiting for a major artificial intelligence (AI) launch from DeepSeek (深度求索), seen as a benchmark for China’s progress in the fast-moving field. More than a year has passed since the start-up put Chinese AI on the map in early last year with a low-cost chatbot that performed at a similar level to US rivals. However, despite reports and rumors about its imminent release, DeepSeek’s next-generation “V4” model is nowhere in sight. Speculation is also swirling over the geopolitical implications of which computer chips were chosen to train and power the new
Elon Musk’s lieutenants have reached out to chip industry suppliers, including Applied Materials Inc, Tokyo Electron Ltd and Lam Research Corp, for his envisioned Terafab, early steps in an audacious and likely arduous attempt to break into the production of cutting-edge chips. Staff working for the joint venture between Tesla Inc and Space Exploration Technologies Corp (SpaceX) have sought price quotes and delivery times for an array of chipmaking gear, people familiar with the matter said. In past weeks, they’ve contacted makers of photomasks, substrates, etchers, depositors, cleaning devices, testers and other tools, according to the people, who asked not to
Japan approved ￥631.5 billion (US$3.97 billion) in additional subsidies to hasten Rapidus Corp’s entry into the high-stakes artificial intelligence (AI) chipmaking arena, ramping up support for a project widely regarded as a long shot. The capital is intended to bankroll Rapidus’ work for information technology firm Fujitsu Ltd, one of the initial customers that Tokyo hopes would get the signature endeavor off the ground. The new money raises the fees and investments that the government is injecting into the start-up to ￥2.6 trillion by the end of the current fiscal year to March next year, the Japanese Ministry of Economy, Trade and
RSS